Advances in genetic engineering and CRISPR technology offer promising avenues for improving HLA matching. Research is ongoing to create "universal" donor cells that are less likely to cause immune reactions. Additionally, the growing use of biobanks and global donor registries aims to increase the availability of compatible donors.
